North America leads this market, holding roughly 41.7% market share and a valuation near USD 0.51 billion in 2024
Neurosci Lett 740:135465
The methylcobalamin form in particular shows nerve-repairing properties, and has been shown to reduce homocysteine levels, treat peripheral neuropathy, ALS, multiple sclerosis, Alzheimer, Bells palsy, and other neurological disorders
These nutrients were chosen because they have the most research supporting their benefits
Conditions like rheumatoid arthritis, fibromyalgia, migraines, autoimmune disorders, and those affecting the central nervous system can lead to these ongoing issues, leaving individuals with constant discomfort and reduced mobility
Skin Rejuvenation GHK-Cu has clinically demonstrated improvements in skin firmness, elasticity, and tone